User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study

This survey study (n=626) investigated user perceptions of the benefits and harms of using LSD, psilocybin, MDMA, cannabis, ketamine, and alcohol. Overall, LSD and psilocybin were regarded as having the most positive impact on well-being and the least harm in terms of physical and mental health.

Abstract of User perceptions of the benefits and harms of hallucinogenic drug use

Introduction: This study used a web-based questionnaire to investigate user perceptions of the benefits and harms of hallucinogenic drug use. Over 600 forms were submitted.

Methods: Users were asked to comment on the acute and prolonged effects of different drugs and to provide more specific information on how particular drugs have harmed and/or helped them.

Results: Subjects reported relatively less harm associated with the classic hallucinogens, LSD and psilocybin, than other drugs specifically focused on in the questionnaire (MDMA, cannabis, ketamine and alcohol). A wide-range of benefits was reported, including: help with mood disorders, addictions and migraine as well as more general long-term improvements in wellbeing. Symptoms of hallucinogen persisting perceptual disorder were reported by a number of subjects and these were most closely associated with use of LSD; however, few users regarded these effects as troubling. Eighty-one per cent of users reported having had a ‘spiritual experience’ on a hallucinogenic drug and over 90% considered ‘access to the unconscious mind’ to be a specific property of the classic hallucinogens.

Discussion: With caution, these findings support recent calls for a systematic investigation of the therapeutic potential of the classic hallucinogens and highlight the scope for empirical investigations of spiritual and psychodynamic phenomena.”

Authors: Robin L. Carhart-Harris & David J. Nutt

Summary of User perceptions of the benefits and harms of hallucinogenic drug use

A web-based questionnaire was used to investigate user perceptions of the benefits and harms of hallucinogenic drug use. The results showed that users reported relatively less harm associated with the classic hallucinogens, LSD and psilocybin, than other drugs specifically focused on in the questionnaire.

This study used a web-based questionnaire to collect information on the perceived benefits and harms of drug use, with a particular focus on hallucinogenic or ‘psychedelic’ drugs. It also sought to address uncertainties regarding the prevalence of flashback phenomena and/or ‘hallucinogen persisting perceptual disorder’.

To access this content, you must purchase one of the following memberships: Sprout Membership, Pro Membership, Pro Membership Unlimited, Business Membership or Business Membership Unlimited. The membership will give you access to exclusive data, including summaries of psychedelic research papers, extended company info, and our member-only visualisations. Save yourself multiple hours each week by accessing Blossom’s resource library.

Find this paper

User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study

https://doi.org/10.3109/14659890903271624

Open Access | Google Scholar | Backup | 🕊

Cite this paper (APA)

Carhart-Harris, R. L., & Nutt, D. J. (2010). User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study. Journal of Substance Use15(4), 283-300.

Study details

Topics studied
Safety Equity and Ethics

Study characteristics
Survey

Participants
626 Humans

Authors

Authors associated with this publication with profiles on Blossom

David Nutt
David John Nutt is a great advocate for looking at drugs and their harm objectively and scientifically. This got him dismissed as ACMD (Advisory Council on the Misuse of Drugs) chairman.

Robin Carhart-Harris
Dr. Robin Carhart-Harris is the Founding Director of the Neuroscape Psychedelics Division at UCSF. Previously he led the Psychedelic group at Imperial College London.

Institutes

Institutes associated with this publication

Imperial College London
The Centre for Psychedelic Research studies the action (in the brain) and clinical use of psychedelics, with a focus on depression.

Linked Research Papers

Notable research papers that build on or are influenced by this paper

Predictors Of Hallucinogen Persisting Perception Disorder Symptoms, Delusional Ideation And Magical Thinking Following Naturalistic Psychedelic Use
This pre-print survey (n=654 start, n=212 end) finds that 33% report a symptom of HPPD (e.g. intensified colours after the trip is finished), but only 3% report the symptoms as disturbing. The study also finds that the personality trait absorption predicts increases in magical thinking at the end-point (4-weeks).

PDF of User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study